Navigation Links
IPC The Hospitalist Company Receives 'Best IPO' Award from Los Angeles Venture Association
Date:1/23/2009

NORTH HOLLYWOOD, Calif., Jan. 23 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, today announced that it has received the "Best IPO" award from the Los Angeles Venture Association (LAVA).

LAVA Executive Director Leonard Lanzi said, "We are pleased to celebrate the success of venture-backed companies, such as IPC. In this environment, anyone who pulls off an IPO with a $237 million valuation should be commended for their efforts. From LAVA's perspective, who was involved and how it happened makes this a story we want to highlight."

LAVA, which recognizes some of Southern California's best growth companies each year, presented awards in various categories to seven companies including IPC. Awards were given at LAVA's 6th Annual Venture Awards Dinner, held in Beverly Hills on January 22, 2009.

IPC Chairman and CEO Adam Singer, M.D., said, "I'm delighted that LAVA chose to acknowledge IPC for its initial public offering last January. Having completed the IPO, as well as a follow-on offering in July 2008, we now have the capital necessary to execute on our growth strategy. We will continue to focus on growing our business by delivering high-quality inpatient care efficiently and cost-effectively."

IPC The Hospitalist Company is the nation's largest private practice hospitalist company, providing hospital medicine services to more than 350 facilities in 18 states. Since the initial public offering, IPC has demonstrated the success of its private practice model -- backed by a scalable business infrastructure with proprietary technology and practice management systems -- through both organic growth and numerous acquisitions of hospitalist practices across the country.

IPC completed its initial public offering in January 2008, raising $83 million. The Company completed a $65 million follow-on offering in July 2008.

About the Los Angeles Venture Association:

Founded in 1985, the Los Angeles Venture Association (LAVA) is the most successful and longest running organization of its kind in Southern California dedicated to the development and growth of entrepreneurial ventures from start-up to middle market.

Through its educational programs and annual conferences, LAVA provides a forum where entrepreneurs meet and learn from fellow executives, investors, bankers, financial advisors and other professional advisors. For more information, visit www.lava.org.

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national hospitalist physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

    Media Contact:                            Investor Contacts:
    Elaine Murphy                             The Ruth Group
    Scott Public Relations                    Stephanie Carrington/Amy Glynn
    818.610.0270                              646.536.7017/7023
    elaine@scottpublicrelations.com           scarrington@theruthgroup.com
                                              aglynn@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company Acquires Missouri Practice Group
2. IPC The Hospitalist Company, Inc. to Present at 27th Annual J.P. Morgan Healthcare Conference
3. Physician Staffing Trends and Hospitalist Jobs Fuel Growth at Locum Leaders
4. IPC The Hospitalist Company Acquires Two Florida Practices
5. Dr. Steven Liu, Founder of Ingenious Med, Recognized as a Leading Hospitalist by the American College of Physicians
6. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
7. IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference
8. IPC The Hospitalist Company Acquires Phoenix Area Practice
9. IPC The Hospitalist Company, Inc. to Report Third Quarter 2008 Financial Results
10. IPC The Hospitalist Company Enters Ohio and Pennsylvania Markets
11. IPC The Hospitalist Company Completes Acquisition of Hospitalists of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... LOUIS (PRWEB) , ... April 26, 2017 , ... ... designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping beverage ... economic alternative to dairy proteins, providing direct cost savings as well as more ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... proud to announce that it has received 510(k) clearance from the U.S. Food ... and the MyoCycle Pro. , Both devices are stationary cycling systems that use ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , the ... This new addition to the Mirroring360 product family combines device screen mirroring with ... Pro enables educators, business professionals and individuals to stream or mirror app screens, ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... California, committed to raising awareness for Duchenne muscular dystrophy, and funding for ... CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President ... are preparing for how his administration could impact the employee benefits industry. James ... changes are most likely to make it through Congress. His discussion will focus ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: